Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spell Capital Partners is a Minneapolis-based private equity firm that specializes in the acquisition of controlling interests in industrial manufacturing and service companies. Founded in 1988, the firm manages both private equity buyouts and mezzanine capital funds, providing financing for leveraged buyouts, recapitalizations, and growth initiatives. While its primary focus is on the industrial sector, Spell Capital has experience investing in healthcare-related manufacturing and medical device components through its portfolio companies. The firm typically targets lower middle-market companies with established management teams and consistent profitability, generally seeking businesses with EBITDA of at least $4 million for buyouts and $2 million for mezzanine financing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spell Capital Partners.